Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Alzheimer's Disease Drugs Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Alzheimer's Disease Drugs Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Alzheimer's Disease Drugs Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Alzheimer's Disease Drugs Market Size Growth Rate by Type
    • 1.4.2 Cholinesterase Inhibitors
    • 1.4.3 NMDA Antagonists
  • 1.5 Market by Application
    • 1.5.1 Global Alzheimer's Disease Drugs Market Size Growth Rate by Application
    • 1.5.2 Drug Stores
    • 1.5.3 Retail Stores
    • 1.5.4 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Alzheimer's Disease Drugs Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Alzheimer's Disease Drugs Industry
      • 1.6.1.1 Alzheimer's Disease Drugs Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Alzheimer's Disease Drugs Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Alzheimer's Disease Drugs Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Alzheimer's Disease Drugs Market Size Estimates and Forecasts
    • 2.1.1 Global Alzheimer's Disease Drugs Revenue 2015-2026
    • 2.1.2 Global Alzheimer's Disease Drugs Sales 2015-2026
  • 2.2 Alzheimer's Disease Drugs Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Alzheimer's Disease Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Alzheimer's Disease Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Alzheimer's Disease Drugs Competitor Landscape by Players

  • 3.1 Alzheimer's Disease Drugs Sales by Manufacturers
    • 3.1.1 Alzheimer's Disease Drugs Sales by Manufacturers (2015-2020)
    • 3.1.2 Alzheimer's Disease Drugs Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Alzheimer's Disease Drugs Revenue by Manufacturers
    • 3.2.1 Alzheimer's Disease Drugs Revenue by Manufacturers (2015-2020)
    • 3.2.2 Alzheimer's Disease Drugs Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Alzheimer's Disease Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Alzheimer's Disease Drugs Revenue in 2019
    • 3.2.5 Global Alzheimer's Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Alzheimer's Disease Drugs Price by Manufacturers
  • 3.4 Alzheimer's Disease Drugs Manufacturing Base Distribution, Product Types
    • 3.4.1 Alzheimer's Disease Drugs Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Alzheimer's Disease Drugs Product Type
    • 3.4.3 Date of International Manufacturers Enter into Alzheimer's Disease Drugs Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Alzheimer's Disease Drugs Market Size by Type (2015-2020)
    • 4.1.1 Global Alzheimer's Disease Drugs Sales by Type (2015-2020)
    • 4.1.2 Global Alzheimer's Disease Drugs Revenue by Type (2015-2020)
    • 4.1.3 Alzheimer's Disease Drugs Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Alzheimer's Disease Drugs Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Alzheimer's Disease Drugs Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Alzheimer's Disease Drugs Revenue Forecast by Type (2021-2026)
    • 4.2.3 Alzheimer's Disease Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Alzheimer's Disease Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Alzheimer's Disease Drugs Market Size by Application (2015-2020)
    • 5.1.1 Global Alzheimer's Disease Drugs Sales by Application (2015-2020)
    • 5.1.2 Global Alzheimer's Disease Drugs Revenue by Application (2015-2020)
    • 5.1.3 Alzheimer's Disease Drugs Price by Application (2015-2020)
  • 5.2 Alzheimer's Disease Drugs Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Alzheimer's Disease Drugs Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Alzheimer's Disease Drugs Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Alzheimer's Disease Drugs Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Alzheimer's Disease Drugs by Country
    • 6.1.1 North America Alzheimer's Disease Drugs Sales by Country
    • 6.1.2 North America Alzheimer's Disease Drugs Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Alzheimer's Disease Drugs Market Facts & Figures by Type
  • 6.3 North America Alzheimer's Disease Drugs Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Alzheimer's Disease Drugs by Country
    • 7.1.1 Europe Alzheimer's Disease Drugs Sales by Country
    • 7.1.2 Europe Alzheimer's Disease Drugs Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Alzheimer's Disease Drugs Market Facts & Figures by Type
  • 7.3 Europe Alzheimer's Disease Drugs Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Alzheimer's Disease Drugs by Region
    • 8.1.1 Asia Pacific Alzheimer's Disease Drugs Sales by Region
    • 8.1.2 Asia Pacific Alzheimer's Disease Drugs Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Alzheimer's Disease Drugs Market Facts & Figures by Type
  • 8.3 Asia Pacific Alzheimer's Disease Drugs Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Alzheimer's Disease Drugs by Country
    • 9.1.1 Latin America Alzheimer's Disease Drugs Sales by Country
    • 9.1.2 Latin America Alzheimer's Disease Drugs Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Alzheimer's Disease Drugs Market Facts & Figures by Type
  • 9.3 Central & South America Alzheimer's Disease Drugs Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Alzheimer's Disease Drugs by Country
    • 10.1.1 Middle East and Africa Alzheimer's Disease Drugs Sales by Country
    • 10.1.2 Middle East and Africa Alzheimer's Disease Drugs Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Alzheimer's Disease Drugs Market Facts & Figures by Type
  • 10.3 Middle East and Africa Alzheimer's Disease Drugs Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Eisai
    • 11.1.1 Eisai Corporation Information
    • 11.1.2 Eisai Description, Business Overview and Total Revenue
    • 11.1.3 Eisai Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Eisai Alzheimer's Disease Drugs Products Offered
    • 11.1.5 Eisai Recent Development
  • 11.2 Forest Laboratories
    • 11.2.1 Forest Laboratories Corporation Information
    • 11.2.2 Forest Laboratories Description, Business Overview and Total Revenue
    • 11.2.3 Forest Laboratories Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Forest Laboratories Alzheimer's Disease Drugs Products Offered
    • 11.2.5 Forest Laboratories Recent Development
  • 11.3 H. Lundbeck
    • 11.3.1 H. Lundbeck Corporation Information
    • 11.3.2 H. Lundbeck Description, Business Overview and Total Revenue
    • 11.3.3 H. Lundbeck Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 H. Lundbeck Alzheimer's Disease Drugs Products Offered
    • 11.3.5 H. Lundbeck Recent Development
  • 11.4 Johnson and Johnson
    • 11.4.1 Johnson and Johnson Corporation Information
    • 11.4.2 Johnson and Johnson Description, Business Overview and Total Revenue
    • 11.4.3 Johnson and Johnson Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Johnson and Johnson Alzheimer's Disease Drugs Products Offered
    • 11.4.5 Johnson and Johnson Recent Development
  • 11.5 Merz Pharma
    • 11.5.1 Merz Pharma Corporation Information
    • 11.5.2 Merz Pharma Description, Business Overview and Total Revenue
    • 11.5.3 Merz Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Merz Pharma Alzheimer's Disease Drugs Products Offered
    • 11.5.5 Merz Pharma Recent Development
  • 11.6 Novartis
    • 11.6.1 Novartis Corporation Information
    • 11.6.2 Novartis Description, Business Overview and Total Revenue
    • 11.6.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Novartis Alzheimer's Disease Drugs Products Offered
    • 11.6.5 Novartis Recent Development
  • 11.7 Pfizer
    • 11.7.1 Pfizer Corporation Information
    • 11.7.2 Pfizer Description, Business Overview and Total Revenue
    • 11.7.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Pfizer Alzheimer's Disease Drugs Products Offered
    • 11.7.5 Pfizer Recent Development
  • 11.1 Eisai
    • 11.1.1 Eisai Corporation Information
    • 11.1.2 Eisai Description, Business Overview and Total Revenue
    • 11.1.3 Eisai Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Eisai Alzheimer's Disease Drugs Products Offered
    • 11.1.5 Eisai Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Alzheimer's Disease Drugs Market Estimates and Projections by Region
    • 12.1.1 Global Alzheimer's Disease Drugs Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Alzheimer's Disease Drugs Revenue Forecast by Regions 2021-2026
  • 12.2 North America Alzheimer's Disease Drugs Market Size Forecast (2021-2026)
    • 12.2.1 North America: Alzheimer's Disease Drugs Sales Forecast (2021-2026)
    • 12.2.2 North America: Alzheimer's Disease Drugs Revenue Forecast (2021-2026)
    • 12.2.3 North America: Alzheimer's Disease Drugs Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Alzheimer's Disease Drugs Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Alzheimer's Disease Drugs Sales Forecast (2021-2026)
    • 12.3.2 Europe: Alzheimer's Disease Drugs Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Alzheimer's Disease Drugs Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Alzheimer's Disease Drugs Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Alzheimer's Disease Drugs Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Alzheimer's Disease Drugs Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Alzheimer's Disease Drugs Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Alzheimer's Disease Drugs Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Alzheimer's Disease Drugs Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Alzheimer's Disease Drugs Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Alzheimer's Disease Drugs Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Alzheimer's Disease Drugs Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Alzheimer's Disease Drugs Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Alzheimer's Disease Drugs Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Alzheimer's Disease Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Alzheimer's Disease Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Alzheimer's Disease Drugs Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Alzheimer's is a chronic neurodegenerative disease that usually starts slowly and worsens over time.
    Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Alzheimer's Disease Drugs market in 2020.
    COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
    The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
    This report also analyses the impact of Coronavirus COVID-19 on the Alzheimer's Disease Drugs industry.
    Based on our recent survey, we have several different scenarios about the Alzheimer's Disease Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Alzheimer's Disease Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
    With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Alzheimer's Disease Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Alzheimer's Disease Drugs market in terms of both revenue and volume.
    Players, stakeholders, and other participants in the global Alzheimer's Disease Drugs market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
    Sales and Pricing Analyses
    Readers are provided with deeper sales analysis and pricing analysis for the global Alzheimer's Disease Drugs market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
    In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
    Regional and Country-level Analysis
    The report offers an exhaustive geographical analysis of the global Alzheimer's Disease Drugs market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
    Competition Analysis
    In the competitive analysis section of the report, leading as well as prominent players of the global Alzheimer's Disease Drugs market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Alzheimer's Disease Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Alzheimer's Disease Drugs market.
    The following manufacturers are covered in this report:
    Eisai
    Forest Laboratories
    H. Lundbeck
    Johnson and Johnson
    Merz Pharma
    Novartis
    Pfizer
    ...
    Alzheimer's Disease Drugs Breakdown Data by Type
    Cholinesterase Inhibitors
    NMDA Antagonists
    Alzheimer's Disease Drugs Breakdown Data by Application
    Drug Stores
    Retail Stores
    Others

    Buy now